SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Intel’s breakup begins with sale of $8.75B-valued Altera to private equity giant Silver Lake

Full list of Israeli high-tech funding rounds in 2025

Fintech Tapcheck raises $225M—$25M Series A extension and $200M facility—to expand real-time pay

Israel leads the world in women in AI

Buzz

Most popular

Daily

Weekly

1

Deel CEO not served in Rippling lawsuit as whistleblower placed under 24/7 guard

2

Ilya Sutskever’s Safe Superintelligence raises $2B at $32B valuation—with no product yet

3

Deel ‘spy’ avoids punishment as Irish court targets company’s CEO and legal team

4

Armis president sets bold goal: $1B in sales in three years, IPO in two

5

Rafael CEO: "Iron Beam will neutralize threats at a negligible cost of less than a dollar"

Cukierman

3 stories about Cukierman

Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Prepare for a year of M&As in Israeli life sciences companies

28.11.21|Laurent Choppe

Massive fund raising, significant growth in M&A deals and even a first Israeli biomed SPAC; Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences, explains the current trends behind the sector's amazing year and discusses what’s next

Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert

17.07.20|Allon Sinai

"We don't talk anymore about devices or drugs. We talk about healthtech convergence, which for me is the future," explains Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences

אדוארד קוקירמן קטליסט

U.S.-China Trade War an Opportunity for Israeli Tech, Says Venture Capitalist

31.10.19|Lilach Baumer

Edouard Cukierman of Cukierman & Co. and Catalyst sees potential in the mounting trade tensions between the U.S. and China, and thinks Israeli companies should steer clear of Chinese politics